Videos

End-To-End Supply Chain Visibility Video

End-To-End Supply Chain Visibility Video

It's been determined that visibility can provide a number of returns for pharma firms. Find out what areas need more visibility in this video.


If you would like a copy of the video sent directly to you, please contact us here.




Highlights From Our 2018 "From Production to Patients" Report

Highlights From Our 2018 "From Production to Patients" Report

Haven't read our "From Production to Patients" Report? Check out this video that highlights key results from the 150+ pharma logistics leaders surveyed.


If you would like a copy of the video sent directly to you, please contact us here.




McKesson, Gilead & GSK on the Cold Chain Industry

McKesson, Gilead & GSK on the Cold Chain Industry

We sat down and spoke with Scott Mooney, Vice President Distribution Operations, Supply Chain Assurance, McKesson Pharmaceutical, Kevin Hickman, Senior Manager, Supply Chain Distribution, Gilead Sciences, Inc, and Javier Gomez-Contreras, Head of Supply Chain Americas, GlaxoSmithKline (GSK) about the top 3 cold chain industry business disruptors, top 3 priorities over the next 12 months, and important recurring industry themes.


If you would like a copy of the video sent directly to you, please contact us here.


Amicus Therapeutics on Patient Centricity in the Temp-Controlled Supply Chains

Amicus Therapeutics on Patient Centricity in the Temp-Controlled Supply Chains

We sat down with John Crowley, Chairman and CEO of Amicus Therapeutics this fall to discussĀ 

  • The macro pressures affecting the cold chain industry that will have a direct impact over the next 12 months
  • What keeps him up at night about cold chain and how he plans on fixing it
  • How is the industry going to achieve the optimal equilibrium between patient-centricity, operational and cost efficiency?
  • His top priorities over the next 12 months